TR201910211T4 - Compounds that increase hematopoietic stem cells. - Google Patents
Compounds that increase hematopoietic stem cells. Download PDFInfo
- Publication number
- TR201910211T4 TR201910211T4 TR2019/10211T TR201910211T TR201910211T4 TR 201910211 T4 TR201910211 T4 TR 201910211T4 TR 2019/10211 T TR2019/10211 T TR 2019/10211T TR 201910211 T TR201910211 T TR 201910211T TR 201910211 T4 TR201910211 T4 TR 201910211T4
- Authority
- TR
- Turkey
- Prior art keywords
- compounds
- stem cells
- hematopoietic stem
- increase hematopoietic
- relates
- Prior art date
Links
- 210000003958 hematopoietic stem cell Anatomy 0.000 title abstract 4
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 210000004027 cell Anatomy 0.000 abstract 2
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 abstract 1
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 abstract 1
- 208000029462 Immunodeficiency disease Diseases 0.000 abstract 1
- 238000011316 allogeneic transplantation Methods 0.000 abstract 1
- 230000007123 defense Effects 0.000 abstract 1
- 208000018706 hematopoietic system disease Diseases 0.000 abstract 1
- 210000000987 immune system Anatomy 0.000 abstract 1
- 230000007813 immunodeficiency Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000002054 transplantation Methods 0.000 abstract 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Mevcut buluş, transplantasyona yönelik CD34+ hücrelerinin sayısının artırılmasına yönelik bileşikler ve bileşimler ile ilgilidir. Buluş ayrıca artırılan hematopoietik kök hücreleri (HSC?ler) içeren bir hücre popülasyonu ve bunun hematopoietik hücre soyları ve immün sistem savunmasını yeniden oluşturmak üzere kalıtsal immün yetmezliği ve otoimmün hastalıkları ve değişken hematopoietik bozuklukları olan hastaların tedavisine yönelik otologöz veya allojeneik transplantasyonda kullanımı ile ilgilidir.The present invention relates to compounds and compositions for increasing the number of CD34 + cells for transplantation. The invention also relates to a cell population containing enhanced hematopoietic stem cells (HSCs) and its use in autologous or allogeneic transplantation for the treatment of patients with hereditary immunodeficiency and autoimmune diseases and variable hematopoietic disorders to regenerate hematopoietic cell lines and immune system defense.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24276509P | 2009-09-15 | 2009-09-15 | |
| US10982109P | 2009-09-15 | 2009-09-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201910211T4 true TR201910211T4 (en) | 2019-08-21 |
Family
ID=67928511
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2019/10211T TR201910211T4 (en) | 2009-09-15 | 2009-10-29 | Compounds that increase hematopoietic stem cells. |
Country Status (1)
| Country | Link |
|---|---|
| TR (1) | TR201910211T4 (en) |
-
2009
- 2009-10-29 TR TR2019/10211T patent/TR201910211T4/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1121857T1 (en) | COMPOUNDS THAT EXPAND HEMAPOPOIETIC STEM CELLS | |
| MX2019002288A (en) | Cell suspension for use in the treatment of lower extremity peripheral artery disease. | |
| JO3266B1 (en) | Silent Fc variants of anti-CD40 antibodies | |
| EP2603227A4 (en) | Improved hematopoietic stem and progenitor cell therapy | |
| BR112013002811A8 (en) | simplified basic means for human pluripotent cell culture | |
| IN2014DN06522A (en) | ||
| EA201290759A1 (en) | ANTIBODIES | |
| WO2012012737A3 (en) | Stable tregs and related materials and methods | |
| EA201391773A1 (en) | CELLS-PRECURSORS OF THE MESODERMAL LINE | |
| UA104663C2 (en) | Antibody binding to cd127 | |
| MA31667B1 (en) | INDUCTION OF TOLEROGENEOUS PHENOTYPE IN MATURE DENDRITIC CELLS | |
| MA38860B1 (en) | Immune-modulating progenitor cell (imp) | |
| FR2898275B1 (en) | CD4 + CD25 + REGULATORY T CELLS SPECIFIC FOR HEMATOPOIETIC CELL TRANSPLANT AND IMMUNE TOLERANCE | |
| WO2012102937A3 (en) | Benz imidazole compounds that expand hematopoietic stem cells | |
| EA201790025A1 (en) | ESTABLISHMENT OF A BANK OF MESENCHYMAL STROMAL CELLS FROM UNITED MONONOCLEAR CELLS OF SEVERAL BONE MARROW DONORS | |
| CA2866116C (en) | Expansion of alloantigen-reactive regulatory t cells | |
| GB201312433D0 (en) | Enhancement of allogeneic hematopoietic stem cell transplantation | |
| EA202090922A1 (en) | COMPOSITIONS AND METHODS FOR DRAINING CD2 + CELLS | |
| WO2006102209A3 (en) | Cd34(+) cells and their methods of use | |
| EA201790883A1 (en) | TOLEROGENIC DENDRITIC CELLS, METHODS OF THEIR RECEIVING AND THEIR APPLICATION | |
| TR201910211T4 (en) | Compounds that increase hematopoietic stem cells. | |
| UA103206C2 (en) | Compounds that expand hematopoietic stem cells | |
| Gu et al. | Experimental Study of Human Gingival Tissue-Derived Mesenchymal Stem Cells in Management of Chronic graft-versushost disease (GVHD) | |
| Ringdén et al. | Decidual Stromal Cells from Placenta-Experimental and Clinical Studies. | |
| 刘代红 | Clinical characteristics of late-onset severe pneumonia after allogeneic hematopoietic stem cell transplantation |